California Clinical Trials Medical Group

Paramount, California 90723

0 studies enrolling now · 5 studies all time

What they study most

Attention Deficit Hyperactivity Disorder, Generalized Anxiety Disorder, Insomnia, Schizoaffective Disorder, Schizophrenia

Studies at this site

• An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia — Completed
• Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo — Stopped early
• Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects — Completed
• Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder. — Completed
• Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia — Completed